HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone844-406-1852
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date9/12/2019 (Estimated)
OptionableOptionable
HEXO (NASDAQ:HEXO) Frequently Asked Questions
What is HEXO's stock symbol?
HEXO trades on the NASDAQ under the ticker symbol "HEXO."
How were HEXO's earnings last quarter?
HEXO Corp. (NASDAQ:HEXO) announced its quarterly earnings results on Thursday, June, 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.01. The business had revenue of $11.98 million for the quarter, compared to analysts' expectations of $10.96 million. View HEXO's Earnings History.
When is HEXO's next earnings date?
What price target have analysts set for HEXO?
8 brokers have issued twelve-month price targets for HEXO's shares. Their predictions range from $7.00 to $12.00. On average, they anticipate HEXO's stock price to reach $8.6340 in the next twelve months. This suggests a possible upside of 115.3% from the stock's current price. View Analyst Price Targets for HEXO.
What is the consensus analysts' recommendation for HEXO?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HEXO.
What are Wall Street analysts saying about HEXO stock?
Here are some recent quotes from research analysts about HEXO stock:
- 1. According to Zacks Investment Research, "HEXO Corp. is a consumer-packaged goods cannabis company. It creates and distributes products to serve the global cannabis market. HEXO Corp. is based in GATINEAU, Quebec. " (8/7/2019)
- 2. Jefferies Financial Group Inc analysts commented, "We initiate at Underperform; PT C$5.60. We think the market has taken the Molson deal as something more indicative of a stronger business than it is. Hexo has a robust medical base but seems ill prepared for solo success beyond that. For us, its stated targeted strategy of primarily being an ingredient provider for Fortune 500 reflects a lack of belief in going alone. If further deals don’t start coming in, or current ones bear fruit, the multiple is at risk." (2/25/2019)
Has HEXO been receiving favorable news coverage?
Media coverage about HEXO stock has trended positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HEXO earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for HEXO.
Who are some of HEXO's key competitors?
Some companies that are related to HEXO include Evotec (EVT), Aphria (APHA), Knight Therapeutics (GUD), OrganiGram (OGI), Green Organic Dutchman (TGOD), Supreme Cannabis (FIRE), HLS Therapeutics (HLS), CannTrust (TRST), Flowr (FLWR), Benchmark (BMK), ICC Labs (ICC), Shield Therapeutics (STX), WeedMD (WMD), Althea Group (AGH) and Harvest One Cannabis (HVT).
What other stocks do shareholders of HEXO own?
Who are HEXO's key executives?
HEXO's management team includes the folowing people:
- Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 35)
- Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 35)
- Mr. Ed Chaplin, CFO & Corp. Sec. (Age 49)
- Mr. James McMillan, VP of Bus. Devel. (Age 51)
- Dr. Terence Lake DVM, Vice-Pres of Corp. & Social Responsibility
Who are HEXO's major shareholders?
HEXO's stock is owned by many different of institutional and retail investors. Top institutional investors include ETF Managers Group LLC (2.60%), Bank of America Corp DE (0.58%), Morgan Stanley (0.37%), TD Asset Management Inc. (0.27%), Royal Bank of Canada (0.21%) and Swiss National Bank (0.16%).
Which major investors are selling HEXO stock?
HEXO stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada and QCI Asset Management Inc. NY.
Which major investors are buying HEXO stock?
HEXO stock was purchased by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Bank of America Corp DE, TD Asset Management Inc., Intact Investment Management Inc., Morgan Stanley, BNP Paribas Arbitrage SA, A.R.T. Advisors LLC and Swiss National Bank.
How do I buy shares of HEXO?
Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HEXO's stock price today?
One share of HEXO stock can currently be purchased for approximately $4.01.
How big of a company is HEXO?
What is HEXO's official website?
How can I contact HEXO?
The company can be reached via phone at 844-406-1852.
MarketBeat Community Rating for HEXO (NASDAQ HEXO)
MarketBeat's community ratings are surveys of what our community members think about HEXO and other stocks. Vote "Outperform" if you believe HEXO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HEXO will underperform the S&P 500 over the long term. You may vote once every thirty days.
